HopeStage
Back to all studies
CompletedNCT00285818

Mifepristone added to electroconvulsive therapy for depression

About this titleRead the official source — NCT00285818
Medication studyAges 18–75United States
The study in practice

Understand this study

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.

Listed locations
StanfordSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2003
Recruitment status
Completed
Enrollment listed in the registry
11
Sponsor
Stanford University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT00285818
Official title
Show the full official title

A Double-blind, Placebo-controlled Study of Mifepristone in Patients With Non-psychotic Major Depressive Disorder Referred for Bilateral Electroconvulsive Therapy (ECT)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Stanford

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Stanford University, a university.

Did this study involve medication?

Yes. The study involved medication, including Mifepristone and Placebo Oral Capsule.

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies